Atropine for the Treatment of Childhood Myopia: Changes after Stopping Atropine 0.01%. 0.1% and 0.5% | Ento Key

Little effect of 0.01% atropine eye drops as used in …

PURPOSE: Daily administration of 0.01% atropine eye drops is a promising approach for myopia control. The mechanism of action is believed to involve the dopaminergic system of the retina, triggering an increased release of dopamine.

Efficacy of Atropine 0.01% for the Treatment of …

CONCLUSION: Low-dose atropine significantly slowed the rate of myopia progression in European paediatric patients with a favourable safety profile. Reference: Efficacy of Atropine 0.01% for the Treatment of Childhood Myopia in European Patients.

CI-MEYC-0110- ϥ 0.01% ~ Myopia Control with Atropine 0.01%)

 · PDF 檔案than -0.50 D while that was -1.20 D in the control group. After withdrawal of atropine for one year after two years of treatment, there was a rapid increase in myopia in children treated with atropine 1% whereas those using atropine 0.01% showed minimal change.

Efficacy and safety of 0.01% atropine for prevention of …

Purpose Atropine eye drops prevent the progression of myopia, but their use has not been tested in the Japanese schoolchildren population. Here, we evaluate the efficacy and safety of 0.01% atropine eye drops for myopia control in Japanese children. Study design
Frontiers
Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119, 347–354. doi: 10.1016/j.ophtha.2011.07.031

Atropine for the Treatment of Childhood Myopia: …

Atropine has been shown in several studies to slow myopia progression in children. In the Atropine Treatment of Myopia trials (ATOM1 and ATOM2), atropine 1.0%, 0.5%, 0.1%, and 0.01% slowed myopia progression by 80%, 75%, 70%, and 60%, respectively

Low-concentration atropine drops safe, effective in …

 · Overall myopia progression during 3 years of treatment was slowest in the 0.01% group, with fewer side effects compared with higher concentrations. The Low-Concentration Atropine for Myopia

[The safety of atropine for myopia prevention and …

Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D Ophthalmology, 119(2):347 |

Pharmacological interventions in myopia …

 · References 1 Chia A, Lu QS, Tan D. Five-year clinical trial on Atropine for the Treatment of Myopia 2: Myopia Control with atropine 0.01% eyedrops. Ophthalmol 2016; 123: 391-399. 2 Yam JC, Jiang Y, Tang SM, Law AKP, et al. Low-concentration Atropine for

Myopia: Translating Science Into Practice

My myopia treatment strategy includes encouraging patients to spend more time outdoors (at least two hours each day), place limits on screen time and take frequent breaks from electronic screens. As far as atropine drops go, I start my patients on 0.01%
Myopia Control Clinic
 · PDF 檔案doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012;119:347-354. 8. Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol

Efficacy and Safety of 0.01% Atropine in Myopic Children …

Prior to treatment, the mean myopia progression was estimated at 1.05D/year; after 12 months of treatment with 0.01% atropine, it was 0.40D/year (p < 0.0001). This represents a 62% reduction in the progression of refractive myopia.

[PDF] Atropine for the treatment of childhood myopia: …

PURPOSE Our previous study, Atropine for the Treatment of Myopia 1 (ATOM1), showed that atropine 1% eyedrops were effective in controlling myopic progression but with visual side effects resulting from cycloplegia and mydriasis. The aim of this study was to compare efficacy and visual side effects of 3 lower doses of atropine: 0.5%, 0.1%, and 0.01%. DESIGN Single-center, double-masked
Myopia Treatments: How to Choose and When to Use?
Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014;157:451-47. Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia: effect

Safety and efficacy of atropine treatment for slowing …

Aim: To report the efficacy and safety of atropine treatment (0.01% and 0.125%) in slowing myopia progression in children. Methods: This is a retrospective non-interventional case series. All patients aged <18 years who received topical atropine for myopia control

Five-Year Clinical Trial on Atropine for the Treatment of …

 · Some 24%, 59%, and 68% of children originally in the atropine 0.01%, 0.1%, and 0.5% groups, respectively, who progressed in phase 2 were restarted on atropine 0.01%. Younger children and those with greater myopic progression in year 1 were more likely to require re-treatment.

atropine eye drops for myopia

Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014;157:451-457 e451. Chia, Audrey et al. Five-Year Clinical Trial on Atropine for the Treatment of Myopia

Effects of 0.01% and 0.02% atropine eye drops on pupil …

Compared with baseline, the PD of 0.01% atropine group and 0.02% atropine group were increased 4, 8 and 12 months after treatment, and the difference was statistically significant (all at P<0.001).